Doping in Sport: A Review of Elite Athletes' Attitudes, Beliefs, and Knowledge

Sports Medicine

Volumn 43, Issue 6, 2013, Pages 395-411

  Morente Sánchez, Jaime ^a,b   Zabala, Mikel ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Doping Prevention Area   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; ATTITUDE TO HEALTH; CULTURAL ANTHROPOLOGY; DOPING; HUMAN; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS;

ATHLETES; CULTURE; DOPING IN SPORTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS;

EID: 84878549956     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-013-0037-x     Document Type: Review

References (65)

1. Bloodworth AJ, McNamee M. Clean Olympians? Doping and anti-doping: the views of talented young British athletes. Int J Drug Policy. 2010;21(4):276-82.
2. WADA (2009a). World anti-doping code [online]. http://www.wada-ama.org/ en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/The-Code. Accessed 29 Nov 2011.
3. Mottram DR. Banned drugs in sport: does the International Olympic Committee (IOC) list need updating? Sports Med. 1999;27(1):1-10. (Pubitemid 29067275)
4. World Anti-Doping Agency. The World anti-doping code. Montreal: WADA; 2003.
5. Gucciardi DF, Jalleh G, Donovan RJ. An examination of the Sport Drug Control Model with elite Australian athletes. J Sci Med Sport. 2011;14(6):469-76.
6. Bahrke MS, Yesalis CE, editors. Performance enhancing substances in sport and exercise. Champaign: Human Kinetics; 2002.
7. Backhouse S, McKenna J, Robinson S, et al. Attitudes, behaviours, knowledge and education - drugs in sport: past present and future [online]. Canada: World Anti-Doping Agency; 2007. http://www.wada-ama.org/rtecontent/ document/Backhouse-et-al-Full-Report.pdf. Accessed 29 Nov 2011.
8. Petroczi A, Aidman E. Measuring explicit attitude toward doping: review of the psychometric properties of the Performance Enhancement Attitude Scale. Psychol Sport Exer. 2009;10:390-6.
9. Dodge T, Jaccard JJ. Is abstinence an alternative? Predicting adolescent athletes' intentions to use performance enhancing substances. J Health Psychol. 2008;13(5):703-11. (Pubitemid 351758648)
10. Donovan RJ, Egger G, Kapernick V, et al. A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Med. 2002;32(4):269-84. (Pubitemid 34293265)
11. Lucidi F, Zelli A, Mallia L, et al. The social-cognitive mechanisms regulating adolescents' use of doping substances. J Sports Sci. 2008;26(5):447-56. (Pubitemid 351266532)
12. Strelan P, Boeckmann RJ. A new model for understanding performance enhancing drug use by elite athletes. J Appl Sport Psychol. 2003;15:176-83. (Pubitemid 36761241)
13. WADA (2009b). World anti-doping agency: Education [online]. http://www.wada-ama.org/en/Education-Awareness/. Accessed 29 Nov 2011.
14. Vangrunderbeek H, Tolleneer J. Student attitudes towards doping in sport: Shifting from repression to tolerance? Int Rev Sociol Sport. 2010;46(3):346-57.
15. Alaranta A, Alaranta H, Holmila J, et al. Self-reported attitudes of elite athletes towards doping: differences between type of sport. Int J Sports Med. 2006;27(10):842-6. (Pubitemid 44622266)
16. Dunn M, Thomas JO, Swift W, et al. Drug testing in sport: the attitudes and experiences of elite athletes. Int J Drug Policy. 2010;21(4):330-2.
17. Pawson R, Tilley N. Realistic evaluation. London: Sage Publications; 1997.
18. Dolan P, Hallsworth M, Halpern D, et al. Influencing behavior: the mindspace way. J Econ Psychol. 2012;33:264-77.
19. Ajzen I. The theory of planned behaviour: some unresolved issues. Organ Behav Hum. 1991;50(2):179-211.
20. Lucidi F, Grano C, Leone L, et al. Determinants of the intention to use doping substances: an empirical contribution in a sample of Italian adolescents. Int J Sport Psychol. 2004;35(2):133-48. (Pubitemid 38963564)
21. Striegel H, Vollkommer G, Dickhuth HH. Combating drug use in competitive sports: an analysis from the athletes' perspective. J Sports Med Phys Fitness. 2002;42(3):354-9.
22. Pitsch W, Emrich E, Kleinm M. Doping in elite sports in Germany: results of a www survey. Eur J Sport Soc. 2007;4(2):89-102.
23. Nieper A. Nutritional supplement practices in UK junior national track and field athletes. Br J Sports Med. 2005;39(9):645-9. (Pubitemid 41265314)
24. Kim J, Kang SK, Jung HS, et al. Dietary supplementation patterns of Korean Olympic athletes participating in the Beijing 2008 Summer Olympic Games. Int J Sport Nutr Exerc Metab. 2011;21(2):166-74.
25. Erdman KA, Fung TS, Doyle-Baker PK, et al. Dietary supplementation of high-performance Canadian athletes by age and gender. Clin J Sport Med. 2007;17(6):458-64. (Pubitemid 350098634)
26. Bloodworth AJ, Petróczi A, Bailey R, et al. Doping and supplementation: the attitudes of talented young athletes. Scand J Med Sci Sports. 2012;22(2):293-301.
27. Lentillon-Kaestner V, Carstairs C. Doping use among young elite cyclists: a qualitative psychosociological approach. Scand J Med Sci Sports. 2010;20(2):336-45.
28. Lentillon-Kaestner V, Hagger MS, Hardcastle S. Health and doping in elite-level cycling. Scand J Med Sci Sports. 2012;22(5):596-606.
29. Dunn M, Thomas JO, Swift W, et al. Elite athletes' estimates of the prevalence of illicit drug use: evidence for the false consensus effect. Drug Alcohol Rev. 2012;31(1):27-32.
30. Petróczi A, Mazanov J, Nepusz T, et al. Comfort in big numbers: does over-estimation of doping prevalence in others indicate self-involvement? J Occup Med Toxicol. 2008;5:3-19.
31. Uvacsek M, Nepusz T, Naughton DP, et al. Self-admitted behavior and perceived use of performance-enhancing vs psychoactive drugs among competitive athletes. Scand J Med Sci Sports. 2011;21(2):224-34.
32. Tangen JO, Breivik G. Doping games and drug abuse. Sportwissenschaft. 2001;31:188-98.
33. Peretti-Watel P, Guagliardo V, Verger P, et al. Attitudes toward doping and recreational drug use among French elite student athletes. Sociol Sport J. 2004;21:1-17. (Pubitemid 38411611)
34. De Hon O, Eijs I, Havenga A. Dutch elite athletes and anti-doping policies. Br J Sports Med. 2011;45(4):341-2.
35. Mottram D, Chester N, Atkinson G, et al. Athletes' knowledge and views on OTC medication. Int J Sports Med. 2008;29(10):851-5.
36. Dascombe BJ, Karunaratna M, Cartoon J, et al. Nutritional supplementation habits and perceptions of elite athletes within a state-based sporting institute. J Sci Med Sport. 2010;13(2):274-80.
37. Breivik G, Hanstad DV, Loland S. Attitudes towards use of performance-enhancing substances and body modification techniques: a comparison between elite athletes and the general population. Sport Soc. 2009;12(6):737-54.
38. Connor JM, Mazanov J. Would you dope? A general population test of the Goldman dilemma. Br J Sports Med. 2009;43(11):871-2.
39. Sas-Nowosielski K, Swiatkowska L. Goal orientations and attitudes toward doping. Int J Sports Med. 2008;29(7):607-12. (Pubitemid 351999433)
40. Waddington I, Malcolm D, Roderick M, et al. Drug use in English professional football. Br J Sports Med. 2005;39(4):e18.
41. Barkoukis V, Lazuras L, Tsorbatzoudisa H, et al. Motivational and sportspersonship profiles of elite athletes in relation to doping behavior. Psychol Sport Exerc. 2011;12(3):205-12.
42. Peretti-Watel P, Pruvost J, Guagliardo V, et al. Attitudes toward doping among young athletes in Provence. Sci Sports. 2005;20(1):33-40. (Pubitemid 40221925)
43. Lazuras L, Barkoukis V, Rodafinos A, et al. Predictors of doping intentions in elite-level athletes: a social cognition approach. J Sport Exerc Psychol. 2010;32(5):694-710.
44. Chester N, Reilly T, Mottram DR. Over-the-counter drug use amongst athletes and non-athletes. J Sports Med Phys Fitness. 2003;43(1):111-8. (Pubitemid 36505754)
45. Striegel H, Ulrich R, Simon P. Randomized response estimates for doping and illicit drug use in elite athletes. Drug Alcohol Depend. 2010;106(2-3):230-2.
46. Pitsch W. The science of doping'' revisited: Fallacies of the current anti-doping regime. Eur J Sport Sci. 2009;9(2):87-95.
47. Berry DA. The science of doping. Nature. 2008;454(7205):692-3.
48. Callaway E. Sports doping: racing just to keep up. Nature. 2011;475(7356):283-5.
49. Hanstad DV, Loland S. Elite athletes' duty to provide information on their whereabouts: justifiable anti-doping work or an indefensible surveillance regime? Eur J Sport Sci. 2009;9(1):3-10.
50. D'Angelo C, Tamburrini C. Addict to win? A different approach to doping. J Med Ethics. 2010;36(11):700-7.
51. Alaranta A, Alaranta H, Heliövaara M, et al. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med. 2006;27(11):919-25. (Pubitemid 44759327)
52. Somerville SJ, Lewis M, Kuipers H. Accidental breaches of the doping regulations in sport: is there a need to improve the education of sportspeople? Br J Sports Med. 2005;39(8):512-6. (Pubitemid 41081329)
53. Peters C, Schulz T, Oberhoffer R, et al. Doping and doping prevention: knowledge, attitudes and expectations of athletes and coaches. Deutsche zeitschrift fur sportmedizin. 2009;60(3):73-8.
54. Thomas JO, Dunn M, Swift W, et al. Illicit drug knowledge and information-seeking behaviours among elite athletes. J Sci Med Sport. 2011;14(4):278-82.
55. Backhouse S, McKenna J. Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs. Int J Drug Policy. 2011;22:198-202.
56. Huang SH, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med. 2006;16(1):27-33. (Pubitemid 43068392)
57. Lamont-Mills A, Christensen S. "I have never taken performance enhancing drugs and I never will": drug discourse in the Shane Warne case. Scand J Med Sci Sports. 2008;18(2):250-8.
58. WADA. Social science research 2008 call for proposal [online]. http://www.wada-ama.org/rtecontent/document/Call-for-Proposals-2009-En.pdf. Accessed 26 Dec 2011.
59. Maughan RJ, Depiesse F, Geyer H. International Association of Athletics Federations: the use of dietary supplements by athletes. J Sports Sci 2007; 25 Suppl. 1:S103-13. Review. Erratum in: J Sports Sci 2009; 27 (6): 667.
60. Thomas JO, Dunn M, Swift W, et al. Elite athletes' perceptions of the effects of illicit drug use on athletic performance. Clin J Sport Med. 2010;20(3):189-92.
61. Perneger TV. Speed trends of major cycling races: does slower mean cleaner? Int J Sports Med. 2010;31(4):261-4.
62. Dunn M, Thomas JO. A risk profile of elite Australian athletes who use illicit drugs. Addict Behav. 2012;37(1):144-7.
63. Zabala M, Sanz L, Durán J, et al. Doping and professional road cycling: perspective of cyclists versus team managers. J Sports Sci Med. 2009;8(11):102-3.
64. Corrigan B, Kazlauskas R. Medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J Sport Med. 2003;13(1):33-40. (Pubitemid 36142924)
65. Zabala M, Atkinson G. Looking for the "athlete 2.0": a collaborative challenge [online]. J Sci Cycling 2012; 1 (1): 1-2. http://www.jsc-journal.com/ojs/index.php?journal=JSC&page=article&op= view&path[]=17&path[]=35. Accessed 03 Aug 2012.